Aller au contenu

The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.

Nom du journal : Clin Breast Cancer

Année : 2024

Volume : 24

Page de départ : 421-430.e3

Auteurs: Debien, V, Agostinetto, E, Bruzzone, M, Ceppi, M, Martins-Branco, D, Molinelli, C & al,